Response of hepatic proteins to 3,5,3'-tri-iodo-L-thyronine in diabetic rats. 1994

T Takeda, and K Ichikawa, and M Kobayashi, and T Miyamoto, and S Suzuki, and Y Nishii, and A Sakurai, and T Nagasawa, and M Katai, and K Nakajima
Department of Geriatrics, Shinshu University School of Medicine, Japan.

In order to study whether peripheral action of thyroid hormones is altered in insulin deficiency and to elucidate the biological consequences of alteration of the cytosolic 3,5,3'-tri-iodo-L-thyronine (T3) binding protein (CTBP), we measured malic enzyme, T3-responsive nuclear n protein, CTBP and nuclear thyroid hormone receptor in the liver and kidney of streptozotocin (STZ)-induced diabetic rats that were treated with or without insulin and/or a receptor-saturating dose of T3. The following results were obtained. 1. Induction of malic enzyme by T3 was apparently diminished in diabetic rats. However, supplementary injection of insulin enabled previously given T3 to take effect in diabetic rats. 2. T3-responsiveness of other hepatic proteins (n protein and CTBP) was not altered by insulin in diabetic rats. 3. The level of n protein was increased by insulin in diabetic rats in vivo and in perfused rat liver, indicating that the hepatic n protein is a novel insulin-responsive protein. T3 and insulin increased the level of n protein non-synergistically in diabetic rat liver. 4. Hepatic nuclear receptor levels were not altered in diabetic rats. 5. Hepatic CTBP levels were decreased in diabetic rats. This was not due to the toxic effect of STZ. Low CTBP level was only partially increased by insulin after 30 days of diabetic period. Renal CTBP levels were not altered in diabetic rats with or without insulin treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008291 Malate Dehydrogenase An enzyme that catalyzes the conversion of (S)-malate and NAD+ to oxaloacetate and NADH. EC 1.1.1.37. Malic Dehydrogenase,NAD-Malate Dehydrogenase,Dehydrogenase, Malate,Dehydrogenase, Malic,Dehydrogenase, NAD-Malate,NAD Malate Dehydrogenase
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D011988 Receptors, Thyroid Hormone Specific high affinity binding proteins for THYROID HORMONES in target cells. They are usually found in the nucleus and regulate DNA transcription. These receptors are activated by hormones that leads to transcription, cell differentiation, and growth suppression. Thyroid hormone receptors are encoded by two genes (GENES, ERBA): erbA-alpha and erbA-beta for alpha and beta thyroid hormone receptors, respectively. Diiodotyrosine Receptors,Receptors, Diiodotyrosine,Receptors, Thyroxine,Receptors, Triiodothyronine,T3 Receptors,T4 Receptors,Thyroid Hormone Receptors,Thyroxine Receptors,Triiodothyronine Receptors,DIT Receptors,Diiodotyrosine Receptor,MIT Receptors,Monoiodotyrosine Receptors,Receptors, DIT,Receptors, MIT,Receptors, Monoiodotyrosine,Receptors, T3,Receptors, T4,T3 Receptor,T4 Receptor,Thyroid Hormone Receptor,Thyroxine Receptor
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols

Related Publications

T Takeda, and K Ichikawa, and M Kobayashi, and T Miyamoto, and S Suzuki, and Y Nishii, and A Sakurai, and T Nagasawa, and M Katai, and K Nakajima
January 2011, International journal of endocrinology,
T Takeda, and K Ichikawa, and M Kobayashi, and T Miyamoto, and S Suzuki, and Y Nishii, and A Sakurai, and T Nagasawa, and M Katai, and K Nakajima
April 1998, The Biochemical journal,
T Takeda, and K Ichikawa, and M Kobayashi, and T Miyamoto, and S Suzuki, and Y Nishii, and A Sakurai, and T Nagasawa, and M Katai, and K Nakajima
January 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
T Takeda, and K Ichikawa, and M Kobayashi, and T Miyamoto, and S Suzuki, and Y Nishii, and A Sakurai, and T Nagasawa, and M Katai, and K Nakajima
December 1979, The Biochemical journal,
T Takeda, and K Ichikawa, and M Kobayashi, and T Miyamoto, and S Suzuki, and Y Nishii, and A Sakurai, and T Nagasawa, and M Katai, and K Nakajima
October 1962, Biochimica et biophysica acta,
T Takeda, and K Ichikawa, and M Kobayashi, and T Miyamoto, and S Suzuki, and Y Nishii, and A Sakurai, and T Nagasawa, and M Katai, and K Nakajima
March 1973, Journal of medicinal chemistry,
T Takeda, and K Ichikawa, and M Kobayashi, and T Miyamoto, and S Suzuki, and Y Nishii, and A Sakurai, and T Nagasawa, and M Katai, and K Nakajima
September 1981, Endocrinology,
T Takeda, and K Ichikawa, and M Kobayashi, and T Miyamoto, and S Suzuki, and Y Nishii, and A Sakurai, and T Nagasawa, and M Katai, and K Nakajima
January 1969, Comptes rendus des seances de la Societe de biologie et de ses filiales,
T Takeda, and K Ichikawa, and M Kobayashi, and T Miyamoto, and S Suzuki, and Y Nishii, and A Sakurai, and T Nagasawa, and M Katai, and K Nakajima
August 1989, The Biochemical journal,
T Takeda, and K Ichikawa, and M Kobayashi, and T Miyamoto, and S Suzuki, and Y Nishii, and A Sakurai, and T Nagasawa, and M Katai, and K Nakajima
March 1975, Bollettino della Societa italiana di biologia sperimentale,
Copied contents to your clipboard!